AB 1682 adds qualifying scalp cooling coverage
Oct 11, 2026 edition · GC-2026-0064 · Published 2026-10-11 · Version 3 · Final
AB 1682 separates large-group scalp-cooling coverage from a conditional Medi-Cal benefit. FDA clearance, prescribed chemotherapy-related use, and cost-sharing limits define the commercial requirement.
What happened
Large-group contracts or policies issued, amended, or renewed from January 1, 2027 must cover prescribed FDA-cleared scalp cooling around alopecia-inducing chemotherapy. Cost sharing may apply, but cannot be less favorable than oncology supportive care. Non-FDA-cleared cold caps are excluded, as are specialized commercial coverage and Medi-Cal managed-care contracts under the commercial provision.
Medi-Cal has a separate prescribed scalp-cooling benefit subject to medical necessity and utilization controls. Its definition likewise excludes non-FDA-cleared products. Implementation depends on necessary federal approvals and available, unjeopardized federal participation; DHCS may issue administrative instructions. These conditions preclude assuming immediate universal reimbursement or applying the large-group mandate to every individual or small-group policy.
Scope and timing
- Authority status
- Final
- Applicability
- Potentially applicable
- Audience
- Health systems, Provider networks
- Jurisdiction
- California
- Affected functions
- Managed Care, Revenue Cycle, IT, Clinical Operations, Compliance
- Responsible owner
- Managed Care
- Recorded date
- 2027-01-01
- Date type
- effective
Why it matters
Large-group plans and insurers may need benefit, medical-necessity, authorization, and claims configuration for prescribed scalp cooling used with chemotherapy.
Recommended action
Confirm affected large-group benefits, medical necessity and coding; track Medi-Cal approvals and guidance rather than assuming immediate universal reimbursement.
Implementation playbook
- Confirm affected benefits, contracts, statutory conditions and applicable dates. Managed Care · Due 2026-10-18
- Confirm affected large-group benefits, medical necessity and coding; track Medi-Cal approvals and guidance rather than assuming immediate universal reimbursement. Managed Care · Due 2027-01-01
- Test revised workflows and member or provider communications before implementation. Compliance · Due 2027-01-01
Sources
- AB-1682 Health care coverage: scalp cooling, bill historyOfficial · California Legislature · 2026-09-03 · Source review 2026-09-10
- AB-1682 Health care coverage: scalp cooling, current bill text (08/30/26 - Enrolled)Official · California Legislature · 2026-08-30 · Source review 2026-09-10
- Governor Newsom issues legislative update 9.27.2026Official · Office of the Governor · 2026-09-27 · Source review 2026-10-04
- AB1682 enacted final textOfficial · California Legislature · 2026-09-27 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →